Review



human immortalized corneal endothelial cell line b4g12  (Creative Bioarray Inc)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 90

    Structured Review

    Creative Bioarray Inc human immortalized corneal endothelial cell line b4g12
    Human Immortalized Corneal Endothelial Cell Line B4g12, supplied by Creative Bioarray Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+corneal+endothelial+cells+line+b4g12/human+corneal+endothelial+cell+line+b4g12/pm37482117-47-4-13
    Average 90 stars, based on 1 article reviews
    human immortalized corneal endothelial cell line b4g12 - by Bioz Stars, 2026-09
    90/100 stars

    Images

    Related Articles

    other:

    Article Title: Type 2 Diabetes Mellitus Makes Corneal Endothelial Cells Vulnerable to Ultraviolet A-Induced Oxidative Damage Via Decreased DJ-1/Nrf2/NQO1 Pathway
    Article Snippet: The human corneal endothelial cells line B4G12 (HCECs) were purchased from Creative Bioarray (Shirley, NY, USA).



    Similar Products

    90
    DSMZ human immortalized corneal endothelial cell line b4g12
    Human Immortalized Corneal Endothelial Cell Line B4g12, supplied by DSMZ, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+corneal+endothelial+cells+line+b4g12/hcec+b4g12/pm38253308-36-6-12
    Average 90 stars, based on 1 article reviews
    human immortalized corneal endothelial cell line b4g12 - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    90
    Creative Bioarray Inc human immortalized corneal endothelial cell line b4g12
    Human Immortalized Corneal Endothelial Cell Line B4g12, supplied by Creative Bioarray Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+corneal+endothelial+cells+line+b4g12/human+corneal+endothelial+cell+line+b4g12/pm37482117-47-4-13
    Average 90 stars, based on 1 article reviews
    human immortalized corneal endothelial cell line b4g12 - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    93
    DSMZ human corneal endothelial cell line
    Human Corneal Endothelial Cell Line, supplied by DSMZ, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+corneal+endothelial+cells+line+b4g12/HCEC-B4G12/pmc09751201-56-17-23
    Average 93 stars, based on 1 article reviews
    human corneal endothelial cell line - by Bioz Stars, 2026-09
    93/100 stars
      Buy from Supplier

    90
    Creative Bioarray Inc human corneal endothelial cells line b4g12
    Human Corneal Endothelial Cells Line B4g12, supplied by Creative Bioarray Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+corneal+endothelial+cells+line+b4g12/human+corneal+endothelial+cell+line+b4g12/pmc09680587-32-2-11
    Average 90 stars, based on 1 article reviews
    human corneal endothelial cells line b4g12 - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    90
    Creative Bioarray Inc human corneal endothelial cell (hcec) line b4g12
    Human Corneal Endothelial Cell (Hcec) Line B4g12, supplied by Creative Bioarray Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+corneal+endothelial+cells+line+b4g12/human+corneal+endothelial+cell+line+b4g12/pmc08899864-19-2-15
    Average 90 stars, based on 1 article reviews
    human corneal endothelial cell (hcec) line b4g12 - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    90
    Creative Bioarray Inc human corneal endothelial cell line b4g12
    Evaluation of MXF-HA efficacy using a rabbit model. ( A ) MXF-HA is inserted into the anterior chamber through a corneal incision while folded by forceps (yellow arrow). The unfolded circular MXF-HA is visible inside the anterior chamber immediately after implantation (white arrows indicate the margin of MXF-HA). ( B ) The implanted MXF-HA was visible on day 1 after surgery (white arrows). However, no visible MXF-HA structures were detected on days 7 and 14 after the surgery. Control is the contralateral eye without MXF-HA insertion. ( C ) MXF concentration was measured using aqueous humor collection. MXF concentrations in aqueous humor were maintained above 8 μg/mL for 5 days. ( D ) The intraocular pressure of MXF-HA-implanted eyes was not significantly different from that of the contralateral control eyes and was maintained within the normal range. ( E ) Eyeballs were harvested and imaged using optical coherence tomography (OCT). Normal corneal structure and thickness were maintained in both MXF-HA and control eyes. Histology (hematoxylin and eosin [H&E] staining) showed normal cellularity in all corneal layers without signs of inflammation in both MXF-HA and control eyes. ( F ) Specular microscopy revealed normal density and morphology of corneal <t>endothelial</t> cells in both MXF-HA and control eyes. *p < 0.05, **p < 0.01, ***p < 0.001.
    Human Corneal Endothelial Cell Line B4g12, supplied by Creative Bioarray Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+corneal+endothelial+cells+line+b4g12/human+corneal+endothelial+cell+line+b4g12/pmc08677739-180-9-15
    Average 90 stars, based on 1 article reviews
    human corneal endothelial cell line b4g12 - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    90
    Bioarray Inc human corneal endothelial cell line (b4g12
    Evaluation of MXF-HA efficacy using a rabbit model. ( A ) MXF-HA is inserted into the anterior chamber through a corneal incision while folded by forceps (yellow arrow). The unfolded circular MXF-HA is visible inside the anterior chamber immediately after implantation (white arrows indicate the margin of MXF-HA). ( B ) The implanted MXF-HA was visible on day 1 after surgery (white arrows). However, no visible MXF-HA structures were detected on days 7 and 14 after the surgery. Control is the contralateral eye without MXF-HA insertion. ( C ) MXF concentration was measured using aqueous humor collection. MXF concentrations in aqueous humor were maintained above 8 μg/mL for 5 days. ( D ) The intraocular pressure of MXF-HA-implanted eyes was not significantly different from that of the contralateral control eyes and was maintained within the normal range. ( E ) Eyeballs were harvested and imaged using optical coherence tomography (OCT). Normal corneal structure and thickness were maintained in both MXF-HA and control eyes. Histology (hematoxylin and eosin [H&E] staining) showed normal cellularity in all corneal layers without signs of inflammation in both MXF-HA and control eyes. ( F ) Specular microscopy revealed normal density and morphology of corneal <t>endothelial</t> cells in both MXF-HA and control eyes. *p < 0.05, **p < 0.01, ***p < 0.001.
    Human Corneal Endothelial Cell Line (B4g12, supplied by Bioarray Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+corneal+endothelial+cells+line+b4g12/b4g12+medium/pmc08677739-180-9-16
    Average 90 stars, based on 1 article reviews
    human corneal endothelial cell line (b4g12 - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    90
    Creative Bioarray Inc human corneal endothelial cells (hcecs) line b4g12
    Evaluation of MXF-HA efficacy using a rabbit model. ( A ) MXF-HA is inserted into the anterior chamber through a corneal incision while folded by forceps (yellow arrow). The unfolded circular MXF-HA is visible inside the anterior chamber immediately after implantation (white arrows indicate the margin of MXF-HA). ( B ) The implanted MXF-HA was visible on day 1 after surgery (white arrows). However, no visible MXF-HA structures were detected on days 7 and 14 after the surgery. Control is the contralateral eye without MXF-HA insertion. ( C ) MXF concentration was measured using aqueous humor collection. MXF concentrations in aqueous humor were maintained above 8 μg/mL for 5 days. ( D ) The intraocular pressure of MXF-HA-implanted eyes was not significantly different from that of the contralateral control eyes and was maintained within the normal range. ( E ) Eyeballs were harvested and imaged using optical coherence tomography (OCT). Normal corneal structure and thickness were maintained in both MXF-HA and control eyes. Histology (hematoxylin and eosin [H&E] staining) showed normal cellularity in all corneal layers without signs of inflammation in both MXF-HA and control eyes. ( F ) Specular microscopy revealed normal density and morphology of corneal <t>endothelial</t> cells in both MXF-HA and control eyes. *p < 0.05, **p < 0.01, ***p < 0.001.
    Human Corneal Endothelial Cells (Hcecs) Line B4g12, supplied by Creative Bioarray Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+corneal+endothelial+cells+line+b4g12/human+corneal+endothelial+cell+line+b4g12/pm32495687-51-2-11
    Average 90 stars, based on 1 article reviews
    human corneal endothelial cells (hcecs) line b4g12 - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    90
    Creative Bioarray Inc human corneal endothelial cells (hcecs) line, b4g12 cells
    Evaluation of MXF-HA efficacy using a rabbit model. ( A ) MXF-HA is inserted into the anterior chamber through a corneal incision while folded by forceps (yellow arrow). The unfolded circular MXF-HA is visible inside the anterior chamber immediately after implantation (white arrows indicate the margin of MXF-HA). ( B ) The implanted MXF-HA was visible on day 1 after surgery (white arrows). However, no visible MXF-HA structures were detected on days 7 and 14 after the surgery. Control is the contralateral eye without MXF-HA insertion. ( C ) MXF concentration was measured using aqueous humor collection. MXF concentrations in aqueous humor were maintained above 8 μg/mL for 5 days. ( D ) The intraocular pressure of MXF-HA-implanted eyes was not significantly different from that of the contralateral control eyes and was maintained within the normal range. ( E ) Eyeballs were harvested and imaged using optical coherence tomography (OCT). Normal corneal structure and thickness were maintained in both MXF-HA and control eyes. Histology (hematoxylin and eosin [H&E] staining) showed normal cellularity in all corneal layers without signs of inflammation in both MXF-HA and control eyes. ( F ) Specular microscopy revealed normal density and morphology of corneal <t>endothelial</t> cells in both MXF-HA and control eyes. *p < 0.05, **p < 0.01, ***p < 0.001.
    Human Corneal Endothelial Cells (Hcecs) Line, B4g12 Cells, supplied by Creative Bioarray Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+corneal+endothelial+cells+line+b4g12/human+corneal+endothelial+cell+line+b4g12/pmc07973544-186-8-19
    Average 90 stars, based on 1 article reviews
    human corneal endothelial cells (hcecs) line, b4g12 cells - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    Image Search Results


    Evaluation of MXF-HA efficacy using a rabbit model. ( A ) MXF-HA is inserted into the anterior chamber through a corneal incision while folded by forceps (yellow arrow). The unfolded circular MXF-HA is visible inside the anterior chamber immediately after implantation (white arrows indicate the margin of MXF-HA). ( B ) The implanted MXF-HA was visible on day 1 after surgery (white arrows). However, no visible MXF-HA structures were detected on days 7 and 14 after the surgery. Control is the contralateral eye without MXF-HA insertion. ( C ) MXF concentration was measured using aqueous humor collection. MXF concentrations in aqueous humor were maintained above 8 μg/mL for 5 days. ( D ) The intraocular pressure of MXF-HA-implanted eyes was not significantly different from that of the contralateral control eyes and was maintained within the normal range. ( E ) Eyeballs were harvested and imaged using optical coherence tomography (OCT). Normal corneal structure and thickness were maintained in both MXF-HA and control eyes. Histology (hematoxylin and eosin [H&E] staining) showed normal cellularity in all corneal layers without signs of inflammation in both MXF-HA and control eyes. ( F ) Specular microscopy revealed normal density and morphology of corneal endothelial cells in both MXF-HA and control eyes. *p < 0.05, **p < 0.01, ***p < 0.001.

    Journal: Scientific Reports

    Article Title: Moxifloxacin releasing intraocular implant based on a cross-linked hyaluronic acid membrane

    doi: 10.1038/s41598-021-03605-0

    Figure Lengend Snippet: Evaluation of MXF-HA efficacy using a rabbit model. ( A ) MXF-HA is inserted into the anterior chamber through a corneal incision while folded by forceps (yellow arrow). The unfolded circular MXF-HA is visible inside the anterior chamber immediately after implantation (white arrows indicate the margin of MXF-HA). ( B ) The implanted MXF-HA was visible on day 1 after surgery (white arrows). However, no visible MXF-HA structures were detected on days 7 and 14 after the surgery. Control is the contralateral eye without MXF-HA insertion. ( C ) MXF concentration was measured using aqueous humor collection. MXF concentrations in aqueous humor were maintained above 8 μg/mL for 5 days. ( D ) The intraocular pressure of MXF-HA-implanted eyes was not significantly different from that of the contralateral control eyes and was maintained within the normal range. ( E ) Eyeballs were harvested and imaged using optical coherence tomography (OCT). Normal corneal structure and thickness were maintained in both MXF-HA and control eyes. Histology (hematoxylin and eosin [H&E] staining) showed normal cellularity in all corneal layers without signs of inflammation in both MXF-HA and control eyes. ( F ) Specular microscopy revealed normal density and morphology of corneal endothelial cells in both MXF-HA and control eyes. *p < 0.05, **p < 0.01, ***p < 0.001.

    Article Snippet: The corneal endothelial safety of MXF-HA was analyzed using human corneal endothelial cell line (B4G12, Creative Bioarray, Shirley, NY, USA).

    Techniques: Control, Concentration Assay, Tomography, Staining, Microscopy

    Comparison of  corneal endothelial cell  density and morphology between MXF-HA-implanted and control eyes in rabbits. Data was described as mean ± standard deviation, and p values were calculated using the Mann–Whitney test.

    Journal: Scientific Reports

    Article Title: Moxifloxacin releasing intraocular implant based on a cross-linked hyaluronic acid membrane

    doi: 10.1038/s41598-021-03605-0

    Figure Lengend Snippet: Comparison of corneal endothelial cell density and morphology between MXF-HA-implanted and control eyes in rabbits. Data was described as mean ± standard deviation, and p values were calculated using the Mann–Whitney test.

    Article Snippet: The corneal endothelial safety of MXF-HA was analyzed using human corneal endothelial cell line (B4G12, Creative Bioarray, Shirley, NY, USA).

    Techniques: Comparison, Control, Standard Deviation